MedTrace Logo

Effect of Early Use of Caffeine Citrate in Preterm Neonates

NCT04001712 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2019-07-02

No results posted yet for this study

Summary

This work is designed to study the effect of the early use of caffeine citrate in preterm neonates who need respiratory support on morbidity and short term neonatal outcome.

Conditions

Interventions

DRUG

Caffeine Citrate

caffeine citrate is given early to preterm neonates in need of respiratory support

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Bassem El Sayed · Ain Shams University

  • Sameh Amer · Medical Military Academy

  • Hisham Awad · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
24 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-05
Primary Completion
2019-05-05
Completion
2019-06-10

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04001712 on ClinicalTrials.gov